CD19 and rheumatoid arthritis: More CD19+ B cells and activated CD69+ and CD8+ T cells were recognized in the lymph nodes of early RA patients and a trend of increasing CD19+ B cells was observed in high-risk subjects, suggesting that B cells play a role in the pathogenesis of LNE [39].